Respiratory distress syndrome. Respiratory distress syndrome of newborn
Conditions
Interventions
Intervention 1: Intervention group: Surfactant injection (Prescribed according to the instructions the manufacturer and section stock) to method of INSURE for all neonates with respiratory distress sy
Treatment - Drugs
Intervention group: Surfactant injection (Prescribed according to the instructions the manufacturer and section stock) to method of INSURE for all neonates with respiratory distress syndrome (RDS) hos
In control group, no intervention was performed and were assessed only for comparison of two groups of the study.
Sponsors
Semnan University of Medical Sciences, Vice Chancellor for Research and Technology
Eligibility
Sex/Gender
All
Age
1 Days to 1 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: premature infants admitted to the neonatal intensive care unit with definitive diagnosis of RDS by pediatrician using clinical symtoms including tachypnea, intercostal retraction, nasal flaring, cyanosis, and hypotension and respiratory arrest. Exclusion criteria: infants with major abnormalities, chromosomal abnormalities, severe asphyxia, and need to Antvbyshn at birth.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of respiratory distress. Timepoint: Before starting study and one hour after Following Prescribing Dosing surfactant. Method of measurement: Based on radiography.;Apgar score. Timepoint: minute one and five Birth. Method of measurement: View Information registered records Filed in the labor. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of respiratory distress. Timepoint: After injecting surfactant. Method of measurement: Based on Picture Radiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Shamsollah Nouripour
Semnan University of Medical Sciences
Outcome results
None listed